Paratek Pharmaceuticals Inc

GEODE CAPITAL MANAGEMENT, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

439,736

Value ($000)

972

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	972	0.0%	439,736	6/30/2023
2023 Q1	5/15/2023	1,186	0.0%	466,795	3/31/2023
2022 Q4	2/13/2023	868	0.0%	464,437	12/31/2022
2022 Q3	11/14/2022	1,135	0.0%	441,935	9/30/2022
2022 Q2	8/12/2022	842	0.0%	436,319	6/30/2022
2022 Q1	5/13/2022	2,394	0.0%	806,113	3/31/2022
2021 Q4	2/11/2022	3,416	0.0%	760,816	12/31/2021
2021 Q3	11/12/2021	3,390	0.0%	697,621	9/30/2021
2021 Q2	8/13/2021	4,940	0.0%	724,407	6/30/2021
2021 Q1	5/12/2021	4,906	0.0%	695,015	3/31/2021
2020 Q4	2/12/2021	3,972	0.0%	634,660	12/31/2020
2020 Q3	11/13/2020	3,195	0.0%	590,647	9/30/2020
2020 Q2	8/13/2020	3,059	0.0%	586,107	6/30/2020
2020 Q1	5/14/2020	1,806	0.0%	573,398	3/31/2020
2019 Q4	2/13/2020	1,913	0.0%	475,229	12/31/2019